人类激肽释放酶2研究进展及其与前列腺癌的关系
被引量:6
摘要
前列腺癌(prostaticcarcinoma,PCa)是欧美地区男性最常见的恶性肿瘤,在美国居所有恶性肿瘤的第一位,病死牢居第二位,仅次于肺癌…。随着老龄化社会的到来和饮食结构的改变,我国人群前列腺癌的发病率呈逐年上升的趋势。南于前列腺癌生长缓慢,早期常无明显症状。发现时多属晚期,预后不良,冈此早期诊断前列腺癌对其治疗及预后具有重要意义。
出处
《中华临床医师杂志(电子版)》
CAS
2012年第8期130-132,共3页
Chinese Journal of Clinicians(Electronic Edition)
参考文献25
-
1Jemal A,Bray F,Center MM. Global cancer statistics[J].CA:A Cancer Journal for Clinicians,2011.69-90.doi:10.3322/caac.20107.
-
2Macefield RC,Lane JA,Metcalfe C. Do the risk factors of age,family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy[J].European Journal of Cancer,2009.2569-2573.
-
3Shariat SF,Semjonow A,Lilja H. Tumor markers in prostate cancer I:blood-based markers[J].Acta Oncologica,2011.61-75.
-
4Jansen FH,Roobol M,Jenster G. Screening for prostate cancer in 2008 II:the importance of molecular subforms of prostate-specific antigen and tissue kallikreins[J].European Urology,2009.563-574.
-
5Vickers AJ,Cronin AM,Roobol MJ. A four-kallikrein panel predicts prostate cancer in men with recent screening:data from the European Randomized Study of Screening for Prostate Cancer,Rotterdam[J].Clinical Cancer Research,2010.3232-3239.
-
6Steuber T,Vickers AJ,Haese A. Risk assessment for biochemical recurrence prior to radical prostatectomy:significant enhancement contributed by human glandular kallikrein 2(hK2)and free prostate specific antigen(PSA)in men with moderate PSA-elevation in serum[J].International Journal of Cancer,2006.1234-1240.
-
7Thompson IM,Ankerst DP,Chi C. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower[J].Journal of the American Medical Association,2005.66-70.
-
8Haroun AA,Hadidy AS,Awwad ZM. Utility of free prostate specific antigen serum level and its related parameters in the diagnosis of prostate cancer[J].Saudi J Kidney Dis Transpl,2011.291-297.
-
9Vickers AJ,Cronin AM,Aus G. A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer:data from the European Randomized Study of Prostate Cancer Screening in Gteborg,Sweden[J].BMC Medicine,2008.19.doi:10.1186/1741-7015-6-19.
-
10Raaijmakers R,de Vries SH,Blijenberg BG. hK2 and free PSA,a prognostic combination in predicting minimal prostate cancer in screen-detected men within the PSA range 4-10 ng/ml[J].European Urology,2007.1358-1364.
同被引文献39
-
1申景涛,郭万华,辛小燕,贾支俊,徐佩,施鸣.PSAD,tPSA,fPSA/tPSA在前列腺癌“诊断灰色带”中的ROC曲线分析[J].现代检验医学杂志,2007,22(5):59-61. 被引量:10
-
2Fried NM, Murray KE. High-power thulium fiber laser ablation of urinary tissues at 1.94 micrometers. JEndourol 2005; 19(1): 25-31.
-
3Bach T, Herrmann TR, Ganzer R, et al. RevoLix vaporesection of the prostate:initial results of 54 patients with a 1-year follow-up. WorldJUro12007;25(3): 257-262.
-
4Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA CancerJClin 2013; 63(1): 11-30.
-
5Mamoulakis C, Schulze M, Skolarikos A, eta1. Midterm results from an international multicentre randomised controlled trial comparing bipolar with monopolar transurethral resection of the prostate. Eur Uro12013; 63(4): 667-676.
-
6Bach T, Herrmann TR, Cellarius C, et al. Bladder neck incision using a 70W, 2 micron continuous wave laser (RevoLix). WorldJUro12007; 25(3): 263-267.
-
7Bach T, Huck N, Wezel F, et al. 70 vs 120 ,W thulium:yttrium-aluminium-garnet 2 microm continuous- wave laser for the treatment of benign prostatic hyperplasia: a systematic ex-vivo evaluation. BJUlnt 2010; 106(3): 368-372.
-
8Wendt-Nordahl G, Huckele S, Honeck P, et al. Systematic evaluation of a recently introduced 2-microm continuous- wave thulium laser for vaporesection of the prostate. J Endouro12008; 22(5): 1041-1045.
-
9沈默,陶志华,周平,李澄棣,陈伟,吴秀玲.血清前列腺特异抗原和前列腺特异抗原密度对前列腺癌诊断价值评价[J].浙江临床医学,2008,10(2):152-153. 被引量:10
-
10叶宗岳,李贤新,来永庆,吴雄辉,黄姗姗,关志忱,叶炯贤.前列腺特异性抗原(PSA)及其相关参数在PSA灰区诊断前列腺癌的临床研究[J].国际泌尿系统杂志,2009,29(5):577-581. 被引量:4
引证文献6
-
1杨冉星,李高峰,俞建军.2μm激光汽化术治疗晚期前列腺癌下尿路梗阻[J].中国男科学杂志,2014,28(11):40-42. 被引量:2
-
2闫骏,黄勇.血清EPCA-2及HK2浓度检测用于早期前列腺癌诊断的研究[J].国际检验医学杂志,2018,39(2):140-142. 被引量:3
-
3燕小朋,张学珍,梁姗.经直肠超声引导下前列腺穿刺活检结合血清PSA早期诊断前列腺癌价值[J].蚌埠医学院学报,2018,43(5):637-638. 被引量:13
-
4李金,罗乐,郑红.经直肠超声联合血清PSA在经会阴前列腺穿刺活检诊断前列腺癌中的价值[J].四川生理科学杂志,2020,42(3):277-280. 被引量:4
-
5周俊红,赵玉保,安瑞.超声引导下经直肠前列腺穿刺活检结合血清前列腺特异性抗原诊断前列腺癌中价值分析[J].实用医技杂志,2020,27(10):1379-1380. 被引量:5
-
6王欢,姚蓓,洪海鸥,程兰.回访管理对PSA异常体检者自我管理能力的影响[J].健康体检与管理,2022,3(2):161-163. 被引量:1
二级引证文献28
-
1彭拓.前列腺增生症所致尿路梗阻利用经尿道前列腺电切术治疗的疗效探析[J].世界最新医学信息文摘,2017,17(16):11-12. 被引量:4
-
2陈珍霖.经直肠超声引导下前列腺穿刺活检结合血清PSA在诊断前列腺癌中的价值体会[J].中国现代药物应用,2018,12(22):39-40. 被引量:3
-
3王翔,王义.超声引导下经直肠前列腺穿刺诊断前列腺癌的价值[J].当代医学,2019,25(25):74-76. 被引量:8
-
4胡德朋,沈柏兰,林昊,郝宝金,徐峰.评价经直肠超声引导改良13点前列腺穿刺活检对前列腺癌的诊断价值[J].影像研究与医学应用,2019,3(24):201-203. 被引量:3
-
5朱国健.经直肠超声引导下前列腺穿刺活检联合血清PSA指标对前列腺癌的诊断价值研究[J].医学食疗与健康,2019,0(17):8-9. 被引量:1
-
6徐文静,陈其华.肾气丸对前列腺癌下尿路症状的临床疗效观察[J].湖南中医药大学学报,2020,40(3):369-372. 被引量:8
-
7石锋,舒松,吴明,余新堂,王曾强.MRI联合TRUS检查对前列腺癌穿刺检出率的影响[J].影像科学与光化学,2020,38(6):1010-1013. 被引量:4
-
8周俊红,赵玉保,安瑞.超声引导下经直肠前列腺穿刺活检结合血清前列腺特异性抗原诊断前列腺癌中价值分析[J].实用医技杂志,2020,27(10):1379-1380. 被引量:5
-
9吴汉潮,张雄伟,王强.前列腺癌诊断方法研究进展[J].中外医学研究,2021,19(7):188-190. 被引量:9
-
10段慧云,黄茜.血清EPCA-2、TNF-α和PSA联合检测在前列腺癌诊断中的应用及与临床病理特征的相关性分析[J].中国医学工程,2021,29(4):135-137. 被引量:4
-
1包香香,帅茨霞,黄引平.人类激肽释放酶基因家族及其在卵巢癌中的研究进展[J].国外医学(妇产科学分册),2004,31(1):40-43.
-
2郑振东,韩涛.胃癌诊疗研究进展[J].临床军医杂志,2017,45(1):1-4. 被引量:33
-
3赵晓敏,李云涛,季国忠.结直肠癌筛查现状与进展[J].中国临床研究,2016,29(6):838-841. 被引量:23
-
4李喜成,李夙恩.多发性骨髓瘤66例临床分析[J].中外健康文摘,2009,6(05X):43-44.
-
5邱朔.基层医院老年全胃切除术47例治疗体会[J].中华腹部疾病杂志,2005,5(1):43-45.
-
6张乃怿,吴成,赵健,陈锐,廖秦平.子宫内膜细胞学检查在筛查子宫内膜癌中的应用[J].中华妇产科杂志,2010,45(10):793-795. 被引量:21
-
7赵红川,耿小平,朱立新.肝细胞肝癌自发性破裂的诊断与治疗[J].中华普通外科杂志,2011,26(2):170-172. 被引量:8
-
8王国民.前列腺癌的放射治疗[J].老年医学与保健,2007,13(3):188-190. 被引量:1
-
9忙尼沙汗.阿不都,玛依努尔.艾力.老年进展期消化道恶性肿瘤21例临床分析[J].新疆医科大学学报,2007,30(9):1030-1031.
-
10张扬,周道平.前列腺癌药物治疗现状与进展[J].安徽医学,2011,32(9):1352-1354. 被引量:4